Effect of Light-Blocking Lenses on Hyperopic Anisometropic Children
A Prospective Randomized Controlled Trial on the Effect of Light-Blocking Lenses on Emmetropization in Hyperopic Anisometropic Children
1 other identifier
interventional
90
1 country
1
Brief Summary
To evaluate the effectiveness of light-blocking lenses in promoting emmetropization and reducing anisometropia in children with hyperopic anisometropia, and to assess the impact of light-intercepting lenses on visual function in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2025
CompletedStudy Start
First participant enrolled
August 25, 2025
CompletedFirst Posted
Study publicly available on registry
August 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
August 27, 2025
August 1, 2025
1.8 years
August 18, 2025
August 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Axial length
measured by optical biometer
At baseline, 6 months, and 12 months
Secondary Outcomes (8)
Refractive error
At baseline, 6 months, and 12 months
Best-corrected visual acuity
At baseline, 6 months, and 12 months
Intraocular pressure
At baseline, 6 months, and 12 months
Angle of deviation
At baseline, 6 months, and 12 months
Contrast sensitivity
At baseline, 6 months, and 12 months
- +3 more secondary outcomes
Other Outcomes (3)
Height
At baseline, 6 months, and 12 months
Weight
At baseline, 6 months, and 12 months
Choroidal thickness (optional)
At baseline, 6 months, and 12 months
Study Arms (2)
Intervention Group
EXPERIMENTALThe eye with higher hyperopia will be fitted with light-blocking lenses for full-time wear, while the fellow eye with lower hyperopia will be fitted with conventional single-vision lenses for full-time wear, over 12 months. Follow-up visits will be scheduled at 6 months (±15 days) and 12 months (±15 days) after lens fitting. Lens replacement will be arranged if a refractive change greater than 0.50 diopters occurs or if the lenses become severely damaged
Control group
PLACEBO COMPARATORBoth eyes of the subjects will be fitted with conventional single-vision lenses for full-time wear over 12-months. Follow-up visits will be scheduled at 6 months (±15 days) and 12 months (±15 days) after lens fitting. Lens replacement will be arranged if a refractive change greater than 0.50 diopters is detected or if the lenses become severely damaged.
Interventions
The eye with higher hyperopia will be fitted with light-blocking lenses for full-time wear, while the fellow eye with lower hyperopia will be fitted with conventional single-vision lenses for full-time wear, over 12 months
Both eyes of the subjects will be fitted with conventional single-vision lenses for full-time wear over 12 months.
Eligibility Criteria
You may qualify if:
- Aged 6 years or older and 12 years or younger;
- The more hyperopic eye has a spherical refractive error between +3.0 D and +7.5 D; the less hyperopic eye has a spherical refractive error of at least +2.0 D; cylindrical refractive error between -2.0 D and 0 D; interocular difference in spherical power \>=1.5 D and in cylindrical power \<=1.0 D;
- Best-corrected visual acuity of 0.0 logMAR or better in both eyes;
- Ocular deviation with spectacles less than 10 prism diopters;
- Has been wearing standard single-vision spectacles regularly for more than six months;
- In good general health, capable of receiving the study intervention, and willing to comply with the study protocol;
- Written informed consent obtained from both the parent/guardian and the child, with agreement to comply with all study procedures and maintain follow-up availability throughout the study period;
You may not qualify if:
- History of ocular trauma or eye surgery;
- Presence of pathological abnormalities on anterior or posterior segment examination, or a history of organic ocular diseases such as cataract, glaucoma, corneal disease, or fundus disorders;
- Intraocular pressure greater than 21 mmHg;
- Presence of systemic diseases or other conditions deemed unsuitable for study participation;
- Any other condition deemed inappropriate for participation in the clinical trial by the investigator;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 18, 2025
First Posted
August 27, 2025
Study Start
August 25, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
August 27, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share